Treatment of schizotypal disorder: a protocol for a systematic review of the evidence and recommendations for clinical practice

被引:1
作者
Gundersen, Kristina Ballestad [1 ,2 ,3 ]
Rasmussen, Andreas Rosen [4 ,5 ,6 ]
Sandstrom, Katharina Oravsky [2 ]
Albert, Nikolai [5 ,7 ]
Polari, Andrea [6 ,8 ]
Ebdrup, Bjorn H. [2 ,5 ]
Nelson, Barnaby [6 ,9 ]
Glenthoj, Louise Birkedal [1 ,3 ]
机构
[1] Copenhagen Res Ctr Mental Hlth, VIRTU Res Grp, Hellerup, Denmark
[2] Univ Copenhagen, Ctr Neuropsychiat Schizophrenia Res CNSR, Mental Hlth Ctr Glostrup, Glostrup, Denmark
[3] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark
[4] Univ Copenhagen, Mental Hlth Ctr Amager, Copenhagen, Denmark
[5] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[6] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia
[7] Copenhagen Res Ctr Mental Hlth CORE, Hellerup, Denmark
[8] Orygen Specialist Program, Parkville, Vic, Australia
[9] Orygen, Parkville, Vic, Australia
来源
BMJ OPEN | 2023年 / 13卷 / 11期
关键词
Schizophrenia & psychotic disorders; PSYCHIATRY; Personality disorders; Systematic Review; MENTAL HEALTH; PERSONALITY-DISORDER; FOLLOW-UP; PHARMACOTHERAPY; INTERVENTION; PERFORMANCE;
D O I
10.1136/bmjopen-2023-075140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Schizotypal disorder is associated with a high level of disability at an individual level and high societal costs. However, clinical recommendations for the treatment of schizotypal disorder are scarce and based on limited evidence. This review aims to synthesise the current evidence on treatment for schizotypal disorder making recommendations for clinical practice.Methods and analysis This systematic review protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A systematic literature search will be performed in PsychArticles, Embase, Medline and Cochrane Central Register of Controlled Trials. Additionally, we will search for relevant articles manually. Inclusion criteria are published studies including individuals diagnosed with schizotypal personality disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria, or schizotypal disorder according to International Classification of Diseases (ICD) criteria. We will include interventional studies comprising any pharmacological and non-pharmacological treatment trials for patients with schizotypal disorder, and all relevant outcome measures will be reported. Risk of bias will be assessed by Cochrane risk-of-bias tools. Data will be synthesised using narrative or thematic analysis and, if suitable, through meta-analysis.Ethics and dissemination No original data will be collected as part of this study and ethics approval is, therefore, not applicable. The results will be disseminated through peer-reviewed publication and presented at international scientific meetings. We will aim at submitting the final paper for publication within 4 months of completion of analyses. Furthermore, this systematic review will inform clinicians and researchers on the current state of evidence on treatment for schizotypal disorder. Findings may guide proposals for further research and potentially guide recommendations for clinical practice using the Grading of Recommendations Assessment, Development and Evaluation.
引用
收藏
页数:6
相关论文
共 43 条
[1]   Course of illness in a sample of patients diagnosed with a schizotypal disorder and treated in a specialized early intervention setting. Findings from the 3.5 year follow-up of the OPUS II study [J].
Albert, Nikolai ;
Glenthoj, Louise Birkedal ;
Melau, Marianne ;
Jensen, Heidi ;
Hjorthoj, Carsten ;
Nordentoft, Merete .
SCHIZOPHRENIA RESEARCH, 2017, 182 :24-30
[2]  
American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders, V4th ed., DOI [DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]
[3]   GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations [J].
Andrews, Jeff ;
Guyatt, Gordon ;
Oxman, Andrew D. ;
Alderson, Phil ;
Dahm, Philipp ;
Falck-Ytter, Yngve ;
Nasser, Mona ;
Meerpohl, Joerg ;
Post, Piet N. ;
Kunz, Regina ;
Brozek, Jan ;
Vist, Gunn ;
Rind, David ;
Akl, Elie A. ;
Schuenemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (07) :719-725
[4]   Misdiagnosis, detection rate, and associated factors of severe psychiatric disorders in specialized psychiatry centers in Ethiopia [J].
Ayano, Getinet ;
Demelash, Sileshi ;
Yohannes, Zegeye ;
Haile, Kibrom ;
Tulu, Mikiyas ;
Assefa, Dawit ;
Tesfaye, Abel ;
Haile, Kelemua ;
Solomon, Melat ;
Chaka, Asrat ;
Tsegay, Light .
ANNALS OF GENERAL PSYCHIATRY, 2021, 20 (01)
[5]   Recent approaches to pharmacotherapy of personality disorders [J].
Bellino, Silvio ;
Rinaldi, Camilla ;
Bozzatello, Paola ;
Bogetto, Filippo .
NEUROPSYCHIATRY, 2011, 1 (03) :259-273
[6]   Treatment utilization by patients with personality disorders [J].
Bender, DS ;
Dolan, RT ;
Skodol, AE ;
Sanislow, CA ;
Dyck, IR ;
McGlashan, TH ;
Shea, MT ;
Zanarini, MC ;
Oldham, JM ;
Gunderson, JG .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (02) :295-302
[7]  
Bleuler E, 1911, DEMENTIA PRAECOX GRO
[8]   Theory of mind and schizotypy: A review [J].
Bohec, A-L ;
Baltazar, M. ;
Tassin, M. ;
Rey, R. .
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2021, 47 (03) :254-262
[9]   Cognitive functions in schizotypal personality disorder [J].
Cadenhead, KS ;
Perry, W ;
Shafer, K ;
Braff, DL .
SCHIZOPHRENIA RESEARCH, 1999, 37 (02) :123-132
[10]   Probability of Transition to Psychosis in Individuals at Clinical High Risk An Updated Meta-analysis [J].
de Pablo, Gonzalo Salazar ;
Radua, Joaquim ;
Pereira, Joana ;
Bonoldi, Ilaria ;
Arienti, Vincenzo ;
Besana, Filippo ;
Soardo, Livia ;
Cabras, Anna ;
Fortea, Lydia ;
Catalan, Ana ;
Vaquerizo-Serrano, Julio ;
Coronelli, Francesco ;
Kaur, Simi ;
Da Silva, Josette ;
Shin, Jae Il ;
Solmi, Marco ;
Brondino, Natascia ;
Politi, Pierluigi ;
McGuire, Philip ;
Fusar-Poli, Paolo .
JAMA PSYCHIATRY, 2021, 78 (09) :970-978